• C.H. Robinson reaffirmed its 2026 operating income outlook, with at least $6 in adjusted diluted EPS at the target range’s bottom.
• The outlook assumes market volume growth of -3% to 1%, despite year-to-date market volumes declining.
• The $5.8 billion RXO acquisition is expected to close in the first half of 2027, generating approximately $300 million in annual cost synergies.
• Adjusted EPS accretion is expected within nine months of closing, reaching mid-teens accretion in 2028.
• Net leverage is targeted at 1.75–2.25 times by year-end 2028; share repurchases have been paused following the acquisition agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C.H. Robinson Worldwide Inc. published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.